Robert L. Bartoszek

Statistics

Publications

Citations

329

H-Index

Active since

2022

Affiliations

University of Pennsylvania(Current)

Parker Institute for Cancer Immunotherapy

Translational Therapeutics (United States)

Robert L. Bartoszek is an author at University of Pennsylvania specializing in chimeric antigen receptor t-cell therapy, immunotherapy, and cancer immunology.

ORCID

Publications per year

2022–2024

Publications

BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion

In-Young Jung, Vivek Narayan, Sierra J. McDonald et al. · Science Translational Medicine · 2022 · 129 citations · Full text

Life Sciences, Immunology, Oncology +17

Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy

Alfred L. Garfall, Adam D. Cohen, Sandra P. Susanibar-Adaniya et al. · Blood Cancer Discovery · 2022 · 76 citations · Full text

Medicine, Hematology, Oncology +17

Tissue-resident memory CAR T cells with stem-like characteristics display enhanced efficacy against solid and liquid tumors

In-Young Jung, Estela Noguera-Ortega, Robert L. Bartoszek et al. · Cell Reports Medicine · 2023 · 62 citations · Full text

Life Sciences, Immunology, Oncology +17

Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T Cell–Intrinsic Dysfunction

In-Young Jung, Robert L. Bartoszek, Andrew J. Rech et al. · Cancer Discovery · 2023 · 34 citations · Full text

Life Sciences, Immunology, Oncology +17

TET2 regulates early and late transitions in exhausted CD8 <sup>+</sup> T cell differentiation and limits CAR T cell function

Alexander J. Dimitri, Amy E. Baxter, Gregory M. Chen et al. · Science Advances · 2024 · 28 citations · Full text

Life Sciences, Cell Biology, Immunology +17

1–5 of 5